Filing Details
- Accession Number:
- 0001140361-23-051260
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-02 21:14:42
- Reporting Period:
- 2023-10-31
- Accepted Time:
- 2023-11-02 21:14:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1305253 | Eiger Biopharmaceuticals Inc. | EIGR | Biological Products, (No Disgnostic Substances) (2836) | 361004130 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1822491 | Leen Kawas | 1900 Avenue Of The Stars, #1000 Los Angeles CA 90067 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-10-31 | 11,987 | $0.26 | 4,379,087 | No | 4 | P | Indirect | See footnote. |
| Common Stock | Acquisiton | 2023-10-31 | 12,345 | $0.26 | 4,391,432 | No | 4 | P | Indirect | See footnote. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnote. |
| No | 4 | P | Indirect | See footnote. |
Footnotes
- Ms. Kawas controls Propel Bio Management LLC, a Delaware limited liability company ("Propel Management"). Ms. Kawas also shares control of Propel Bio Partners LLC, a Delaware limited liability company ("Propel General Partner"). Ms. Kawas, Propel Management and Propel General Partner act as the investment advisor to, or general partner of, or otherwise provide discretionary advisory services to, one or more private investment funds, and such investment funds acquired the referenced shares of Common Stock.
- Ms. Kawas expressly disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of any pecuniary interest.
Billionaire Hedge Funds
